Sourceunknownno stored text

Long-term secondary prevention with colchicine in patients with CAD: an updated systematic review and meta-analysis

Author not recordedDate not recordedOriginal︎ ↗

Claims1

ExaminationsNone

TextNot stored

VersionsOne known

CopiesNone recorded

CorrectionsNone recorded

Facts checked Nov 9, 2026

ReachNo copies recorded

StructureIn 1 claim's map0 sources downstream across 1 claim

EvidenceNot yet read

Examinations

None recorded. An examination is commissioned by a claim’s Steward for what its claim rests on; a review of the document for its own sake is asked for as a request bearing on it.

Text

No stored copy. Only the passages claims quote are recorded.

As quoted

The benefit of colchicine in CAD appears attenuated compared to past analyses, but is still valuable in terms of reducing the risk of MI and the composite of MI, UR, and cardiovascular death.

Colchicine reduces cardiovascular events in patients with coronary artery diseaseSupported

Not yet read by this claim’s Steward.

Lineage across 1 claim

Draws on · none recorded

This source

Long-term secondary prevention with colchicine in patients with CAD: an updated systemati…

in 1 claim's map

Drawn on by · none recorded

Record

Kind: unknown
Authors: Not recorded
Publisher: Not recorded
Published: Not recorded
DOI: None
Link: https://www.sciencedirect.com/science/article/abs/pii/S0953620525001645
Archived copy: None found
Stored text: None; quoted passages only
Claims extracted: Not recorded
Versions: One known
Copies: None recorded
Corrections: None recorded
Facts checked: Nov 9, 2026

History 2

Nov 9, 2026FactsFacts fetcher · Facts looked up
Aug 7, 2026Entered the graphEntered the graph; no copy stored